Tert-butyl N-[4-[[(1S)-3-[4-[2-[4-[[4-[(2R)-2-amino-2-cyclohexylacetyl]piperazin-1-yl]methyl]piperidin-1-yl]acetyl]piperazin-1-yl]-1-(4-chlorophenyl)propyl]carbamoyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]carbamate
C50H75ClN12O5 — CID 176761090
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[4-[[(1S)-3-[4-[2-[4-[[4-[(2R)-2-amino-2-cyclohexylacetyl]piperazin-1-yl]methyl]piperidin-1-yl]acetyl]piperazin-1-yl]-1-(4-chlorophenyl)propyl]carbamoyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]carbamate
Tert-butyl N-[4-[[(1S)-3-[4-[2-[4-[[4-[(2R)-2-amino-2-cyclohexylacetyl]piperazin-1-yl]methyl]piperidin-1-yl]acetyl]piperazin-1-yl]-1-(4-chlorophenyl)propyl]carbamoyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]carbamate (PubChem CID 176761090) has the molecular formula C50H75ClN12O5 and a molecular weight of 959.68 g/mol. Its IUPAC name is tert-butyl N-[4-[[(1S)-3-[4-[2-[4-[[4-[(2R)-2-amino-2-cyclohexylacetyl]piperazin-1-yl]methyl]piperidin-1-yl]acetyl]piperazin-1-yl]-1-(4-chlorophenyl)propyl]carbamoyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]carbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[4-[[(1S)-3-[4-[2-[4-[[4-[(2R)-2-amino-2-cyclohexylacetyl]piperazin-1-yl]methyl]piperidin-1-yl]acetyl]piperazin-1-yl]-1-(4-chlorophenyl)propyl]carbamoyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]carbamate |
|---|---|
| PubChem CID | 176761090 |
| Molecular Formula | C50H75ClN12O5 |
| Molecular Weight | 959.68 g/mol |
| Exact Mass | 958.57 |
| IUPAC Name | tert-butyl N-[4-[[(1S)-3-[4-[2-[4-[[4-[(2R)-2-amino-2-cyclohexylacetyl]piperazin-1-yl]methyl]piperidin-1-yl]acetyl]piperazin-1-yl]-1-(4-chlorophenyl)propyl]carbamoyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]carbamate |
| SMILES | CC(C)(C)OC(=O)NC1(C(=O)N[C@@H](CCN2CCN(C(=O)CN3CCC(CN4CCN(C(=O)[C@H](N)C5CCCCC5)CC4)CC3)CC2)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1 |
| InChI | InChI=1S/C50H75ClN12O5/c1-49(2,3)68-48(67)57-50(17-23-62(24-18-50)45-40-13-19-53-44(40)54-35-55-45)47(66)56-41(37-9-11-39(51)12-10-37)16-22-58-25-29-61(30-26-58)42(64)34-59-20-14-36(15-21-59)33-60-27-31-63(32-28-60)46(65)43(52)38-7-5-4-6-8-38/h9-13,19,35-36,38,41,43H,4-8,14-18,20-34,52H2,1-3H3,(H,56,66)(H,57,67)(H,53,54,55)/t41-,43+/m0/s1 |
| InChIKey | XIQYUVXTBUOJEI-BXEVYTFUSA-N |
| XLogP | 4.63 |
| TPSA | 188.60 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 68 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 959.68 |
| LogP ≤ 5 | 4.63 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176761090 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.